Journal of Reports in Pharmaceutical Sciences

RESEARCH ARTICLE
Year
: 2017  |  Volume : 6  |  Issue : 1  |  Page : 51--58

Effect of scopolamine and mecamylamine on antidepressant effect of rivastigmine in a behavioral despair test in mice


Azadeh Mesripour1, Valiollah Hajhashemi2, Hasan Fakhr-hoseiny2 
1 Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical sciences, Isfahan university of Medical Sciences, Isfahan, Iran
2 Department of Pharmacology and Toxicology, School of Pharmacy and Pharmaceutical Sciences, Isfahan university of Medical Sciences, Isfahan, Iran

Correspondence Address:
Azadeh Mesripour
Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical sciences, Isfahan university of Medical Sciences, Isfahan
Iran

Rivastigmine can decrease the severity of depression in Alzheimer's disease patients. Apart from the monoamines hypothesis of despair, it is well known that the cholinergic system is also responsible. Thus regarding the antidepressant effect of rivastigmine, the aim was evaluating the influence of scopolamine (muscarinic cholinergic receptors antagonist) and/or mecamylamine (nicotinic cholinergic receptors antagonist) co-administration with rivastigmine on depression outcome. Depression was evaluated by the tail suspension test (TST) in male mice. Immobility time was recorded manually which represents the time that animal stops attempts for escape from the unpleasant situation. Imipramine as the reference antidepressant decreased this time by increasing the hope for escape in the animal. Rivastigmine (0.75 mg/kg,sc), scopolamine and/or mecamylamine (0.5 and 1 mg/kg, ip, respectively) were injected before the TST. Rivastigmine considerably reduced the immobility time compared with the control group which indicated its antidepressant effects. The combination treatment of rivastigmine and scopolamine also reduced the immobility time compared with control. Mecamylamine co-administration with rivastigmine increased the immobility time which indicated that it prevented the antidepressant effects of rivastigmine. Ultimately by using the drugs all together the immobility time notably decreased. Therefore our results proved that nicotine cholinergic receptorstimulation is prominent in the antidepressant effects of rivastigmine. Thus nicotine receptor direct or indirect stimulants could be considered for further researches regarding antidepressants.


How to cite this article:
Mesripour A, Hajhashemi V, Fakhr-hoseiny H. Effect of scopolamine and mecamylamine on antidepressant effect of rivastigmine in a behavioral despair test in mice.J Rep Pharma Sci 2017;6:51-58


How to cite this URL:
Mesripour A, Hajhashemi V, Fakhr-hoseiny H. Effect of scopolamine and mecamylamine on antidepressant effect of rivastigmine in a behavioral despair test in mice. J Rep Pharma Sci [serial online] 2017 [cited 2020 Aug 14 ];6:51-58
Available from: http://www.jrpsjournal.com/article.asp?issn=2322-1232;year=2017;volume=6;issue=1;spage=51;epage=58;aulast=Mesripour;type=0